Jerome Belinson MD
Jerome L Belinson, MD is the Ex-officio Chairman of the Department of Obstetrics and Gynecology at the Cleveland Clinic Foundation 1990-2000. He has dedicated his career to advancing the screening and treatment of gynecologic cancers.
Dr. Belinson serves as Professor of Surgery with the Cleveland Clinic Lerner College of Medicine of the Case Western Reserve University. He trained in Obstetrics and Gynecology at Columbia University’s Presbyterian Hospital in New York City, and was a Fellow in Gynecologic Oncology at the University of Miami, Jackson Memorial Hospital. Dr Belinson began the first formal gynecologic oncology service at the University of Vermont in 1977. He has previously held full professorships at the University of Vermont (tenured) and The Ohio State University.
Voted Teacher of The Year at the University of Vermont, and on two occasions at the Cleveland Clinic, Dr. Belinson received the 2004 distinguished graduate Citation of Merit from the University of Missouri Medical School, The Bruce Hubbard Stewart Award for Humanitarianism in Medicine at the Cleveland Clinic, and is consistently listed among the “Best Doctors in America”.
Dr. Belinson is the founding director of Preventive Oncology International, Inc. (“P.O.I.”), a research organization that blends humanitarian work with investigative science. Dr. Belinson has served as an Advisor to the Ministry of Science in India, the medical advisory board for the Gates Foundation START project (to develop a rapid, low cost HPV test), and serves on the Board of Directors of Grounds for Health, an organization that provides care for women in coffee-growing regions of the world, and the Global Initiative Against HPV and Cervical Cancer.
Dr Belinson has worked for more than 20 years in many rural Chinese provinces. His initial study, known as SPOCCS I, received international acclaim and continues to serve as a model for study design in epidemiology courses around the world.
In 2010 Dr. Belinson was awarded “The People’s Republic of China Friendship Award.” This award, established in the 1950’s, is the People’s Republic of China’s highest award for foreign experts who have made outstanding contributions to the country’s economic and social progress.
Dr. Belinson and his colleagues of Preventive Oncology International, Inc. have also been recognized for their careful adherence to and promotion of human values and the proper conduct of studies involving human subjects in the developing world. Over the past 15 years many studies have been completed resulting in dozens of publication and presentations at national and international meetings.In addition to many scientific contributions, the work of P.O.I. has resulted in the approval of liquid based cytology and HPV testing in China, the introduction of many other new technologies, as well as numerous educational sessions and international exchanges for Chinese physicians. These activities lead his Chinese collaborators to develop a cervical cancer consortium throughout China, and also lead to collaborations between the Chinese and the World Health Organization and the Gates Foundation. Most importantly, almost 50,000 women who have participated in the studies received screening for cervical cancer, often for the only time in their lives.
Xin Feng Qu, MD
Chief Operating Officer, China
Dr. Qu Xinfeng is the China-based administrator of Preventive Oncology International Inc. (POI). His responsibilities include implementation of the POI conducted research, coordination with the Chinese collaborators, resource integration, China business management and government affairs. He has been working for POI-China since 2009. He played a key role in SHENCCAST I, SHENCCAST II, SHENCCAST III, PUSH OTC II, and CHICAPS I, with his contributions in business model design, financial projecting, project programming, project administration, specimen and data management, and site implementation. He is one of the key developers of the Community Based Participatory Screening Model in CHICAPS..
Before working with POI, Dr. Qu had 10 years of experience in senior management positions with a variety of international companies. He was the CEO of Boai Medical Group, taking responsibilities for the operation of 6 company hospitals. Before that, he was the deputy president of Greencool Group and Kelon Electronic Corporation Ltd., in charge of international finance and investment (mainly focused on equity acquisition). He also had 3 years of working experience as the Chief Representative of Binnie Black & Vertch, Ltd., a UK based infrastructure engineering and consulting service, with full responsibilities for its business in hydropower, environmental and water supply projects.
Dr. Qu had 8 years of academic experiences as a faculty member of the Medical School of Hebei University from 1985-1993, and 3 years of experiences as an official of Public Health Ministry of China from 1994-1997. During those periods, his focus was in public-health-related sociology and health related behavioral sciences. His main duty as the government official was planning, programing and evaluation of the 3 World Bank financed Rural Water Supply and Sanitation Projects.
Nancy Tresser, MD MBA
Chief Operating Officer, USA
Dr. Tresser started her medical research work as an undergraduate at the University of Michigan (BS 1982). She continued pursuing her interest in clinical research while at the University of Michigan Medical School with Ray Littleton, MD (MD 1987). At University Hospitals of Cleveland she completed an internship in General Surgery and a fellowship in Neuropathology. She completed two years of residency in anatomic pathology at Mt. Sinai Medical Center in Cleveland. Her clinical research career began with academic positions at University Hospitals of Cleveland/Case Western Reserve University and University of South Florida/Moffitt Cancer Center/James A Haley VA Hospital. She was invited to the National Institutes of Health, National Institute of Neurological Disorders and Stroke (NIH, NINDS) in 1996 as a special expert in neuropathology. While at the NIH she had the opportunity to work with 45 diverse research groups providing Neuropathology support. Dr. Tresser is proud to have contributed to the outstanding work on human iron metabolism completed in the laboratories of Tracey A. Rouault, MD of the National Institute of Child Health and Human Development (NICHD) and on Neuroimmunology in the laboratories of Henry McFarland of the NINDS.
In 2005, after receiving an MBA, Dr. Tresser joined biotech startup Imalux® as their Medical Director. She was promoted to Vice President, Chief Medical Officer at Imalux in 2006. While at Imalux she worked with clinical researchers in Europe, China, Australia, and the United States on studies using the Niris® Optical Coherence Tomography Systems 1300 and 1300e in Urology, Obstetrics and Gynecology, Otolaryngology, Gastroenterology, Pulmonology, Orthopedics, Oral Surgery, Transplant and Dentistry. Dr. Tresser collaborated with Jerome Belinson, MD and POI on OCT studies PUSH I, II and III.
Dr. Tresser is board certified in Anatomic Pathology/Neuropathology and holds active medical licenses for the states of Ohio, Michigan and Hawaii. In 2003 Dr. Tresser received a Masters Degree in Business Administration (MBA) from Weatherhead School of Management at Case Western Reserve University. She completed certified training as a Principal Investigator for Pharmaceutical Investigational Products and Good Clinical Practices through CITI (2013).